期刊文献+

多支血管病变患者的血运重建策略 被引量:1

Revascularization Strategy for Patients with Multivessel Disease
下载PDF
导出
摘要 多支血管病变患者的治疗策略选择,应充分考虑各种因素。与单支血管病变患者相比,多支血管病变患者往往合并糖尿病、肾功能不全、既往心肌梗死史和左室射血分数减低。多支血管病变患者的冠状动脉常为钙化、慢性完全闭塞、弥漫和小血管病变,而导致操作过程复杂。血运重建策略的选择应综合考虑所有这些临床、解剖和操作因素。 When approaching a patient with muhivessel disease, there are many factors that should be considered. In comparison with patients who have single-vessle coronary artery disease, these patients are more likely to have multiple comorbid conditions, including diabe- tes, renal insufficiency, prior myocardial infarction (MI) , and reduced left ventricular. They are also more likely to require complex proce- dures for anatomical reasons such as calcified lesions, chronic total occlusions, and diffusely diseased and smaller vessels. All these clinical, anatomic, and procedural variables influence decisions regarding the revascularization strategy.
出处 《心血管病学进展》 CAS 2009年第2期197-200,共4页 Advances in Cardiovascular Diseases
关键词 多支病变 血运重建策略 multivesse disease revascularization strategy
  • 相关文献

参考文献21

  • 1Tan WA,Tamai H, Park S J, et al. Long-term clinical outcomes after unprotected left main trunk percutaneous revascularization in 279 patients [ J ]. Circulation, 2001,104:1609-1614.
  • 2Valgimigli M ,van Mieghem CA ,Ong AT,et al. Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital registries ( RESEARCH and T-SEARCH) [J]. Circulation,2005,111:1383-1389.
  • 3Al Suwaidi J, Berger PB, Rihal CS, et al. Immediate and long-term outcome of intracoronary stent implantation for true bifurcation lesions[J]. J Am Coll Cardiol,2000,35:929-936.
  • 4Hoye A, lakovou I, Ge L, et al. Long-term outcomes after stenting of bifurcation lesions with the " crush" technique : predictors of an adverse outcome [ J ]. J Am Coll Cardiol,2006,47 : 1949-1958.
  • 5Nakamura S, Muthusamy TS,Bae JH, et al. Impact of sirolimus-eluting stent on the outcome of patients with chronic total occlusions [ J ]. Am J Cardiol, 2005, 95 : 161-166.
  • 6Baskett R, Buth K, Ghali W, et al. Outcomes in octogenarians undergoing coronary artery bypass grafting [ J ]. C MAJ, 2005,172 : 1183-1186.
  • 7Sadeghi HM, Grines CL, Chandra HR, et al. Percutaneous coronary interventions in octogenarians glycoprotein Ⅱb/Ⅲa receptor inhibitors' safety profile [ J ]. J Am Coll Cardiol,2003 ,42 :428-432.
  • 8Weintraub WS,Jones EL, King SB 3rd, et al. Changing use of coronary angioplasty and coronary bypass surgery in the treatment of chronic coronary artery disease [ J ]. Am J Cardiol, 1990,65 : 183 -188.
  • 9le Feuvre C, Bonan R, Cote G, et al. Five- to ten-year outcome after muhivessel percutaneous transluminal coronary angioplasty [ J ]. Am J Cardiol, 1993,71 : 1153-1158.
  • 10O' Keefe JH Jr, Rutherford BD, McConahay DR, et al. Multivessel coronary angioplasty from 1980 to 1989: procedural results and long-term outcome [ J ]. J Am Coll Cardiol, 1990,16 : 1097-1102.

同被引文献12

  • 1游桂英,祝烨,余建英,刘小菁.冠心病患者血浆胎盘生长因子水平的研究[J].四川大学学报(医学版),2007,38(3):466-467. 被引量:6
  • 2Maglione D, Guerriero V, Viglietto G, et al. Two alternative mRNAs cod- ing for tile angiogenic factor, placenta growth factor (PLGF), are tran- scribed from a single gene of chromosome 14[J]. Oncogene, 1993,8(4): 925 - 931.
  • 3Roy H, Bhardwaj S, Babu M, et al. Adenoviras-mediated gene transfer of placental growth factor to per/vascular tissue induces angiogenes~s via upreg- ulation of the expression of endogerous vascular endothelial growth factor-A [J]. UumGeneTher,2005,16(12):1422-1428.
  • 4Oura H, Bertoncini J, Velasco P, et al. A critical role of placental growth factor in the induction of inflammation and edema formation[J]. Blood, 2003,101(2) :560 - 567.
  • 5Wu AH. Markers for early detection of cardiac diseases[J]. Scand J Clin Lab Invest Suppl,2005,240:112- 121.
  • 6Tarnow L, Astrup AS, Parving HH. Elevated placental growth factor (PLGF) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy [ J ]. Scand J Clin Lab Invest Suppl, 2005.240:73 - 79.
  • 7Selvaraj SK, Giri RK, Perelman N, et al. Mechanism of monocyte activa- tion and expression of proinflammatory cytochemokines by placenta growlh factor[J]. Blood,2003,102(4) : 1515 - 1524.
  • 8Lutttm A, Tjwa M, Moons L, et al. Revascularization of ischemic tissuesby PLGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclemsis by anti-Fltl[J]. Nat Med,2002,8(8) :831 - 840.
  • 9Heeschen C, Dimmeler S, Fichtlscherer S, et al. Prognostic value of pla- cental growth factor in patients with acute chest pain[ J]. JAMA, 2004,291 (4) :435 - 441.
  • 10Lenderink T, Heeschen C, Fichtlscherer S, et al. Elevated placental growth factor levels are associated with adverse outcomes at four-year follow- up in patients with acute coronary syndromes[J]. J Am Coil Cardiol,2006, 47(2) :307 - 311.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部